Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06849037 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion moved earlier from Feb 13, 2028 to Feb 13, 2027 Show 4 more changesShow less
    • Study completion moved earlier from Feb 13, 2029 to Feb 13, 2028
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Publications: details revised at 5 of 5 entries
  2. Start date changed from estimate of Feb 25, 2025 to Feb 18, 2025
    • Secondary endpoints: details revised at 1 of 3 entries
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our randomized controlled double blind clinical trail aims to compare maternal and neonatal infectious morbidity between women with meconium-stained amniotic fluid treated with zinacef vs. placebo.
Trial Details
NCT Number NCT06849037
Lead Sponsor Western Galilee Hospital-Nahariya
Conditions
(from sponsor)		 Meconium-stained Amniotic Fluid, Chorioamnionitis
Related terms Chorioamnionitis
Enrollment 182 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov